St. Louis-based Homer G. Phillips Memorial Hospital is close to missing a state deadline to reopen after the hospital temporarily closed in December when its license was suspended due to a blood supply shortage.
Category: Static
Children's hospitals launch national 'Safety Watch'
The Children’s Hospital Association’s Child Health Patient Safety Organization has developed a new “Safety Watch” initiative to help pediatric clinicians identify healthcare risks and prevent harm.
UVA Health board member resigns 1 week after CEO
Thomas Scully resigned from the UVA Health System board March 6 in protest of the University of Virginia’s treatment of former CEO K. Craig Kent, MD, The Daily Progress reported March 10.
Why Epic is building AI agents into its EHR
Epic is developing AI agents that can autonomously perform tasks that used to require humans.
Novo Nordisk drug yields 15.7% weight loss in phase 3 trial
An experimental obesity drug from Novo Nordisk resulted in 15.7% weight loss after 68 weeks of treatment — falling short of the company’s expectations of 25% weight loss.
Prospect's Crozer Health averts closure — for now
A deal has been reached to keep Upland, Pa.-based Crozer Health open “for the immediate future” after its parent company, Los Angeles-based Prospect Medical Holdings, shared plans to close Crozer’s two remaining hospitals in early March.
What CommonSpirit's CNO discovered on a break from nursing
Kathy Sanford, executive vice president and chief nursing officer of CommonSpirit Health, oversees a team of 45,000 nurses systemwide. Her leadership helped guide the health system’s clinical team through the pandemic and will be integral in the next p…
Fitch boosts Providence's outlook to stable after operating improvements
Fitch affirmed Renton, Wash.-based Providence’s “A” rating and revised its outlook to stable from negative.
HHS gives $25K buyout option to all employees
All of HHS’s around 80,000 employees received a voluntary buyout offer of $25,000 on March 7 to resign from their jobs, according to a March 8 report from NBC News.
Drug doubles glioblastoma survival time in trial
Researchers from the University of Texas Health Science Center at San Antonio have developed a drug that more than doubled median survival time and progression-free time for patients with glioblastoma during a clinical trial.
